CANCER

Recommendations

Info

Bloodwise 62 Notes to the Accounts for the year ended 31 March 2015 Notes to the accounts for the year ended 31 March 2015 (continued) 12 GRANTS APPROVED IN THE YEAR, SHOWN BY INSTITUTION – GROUP AND BLOODWISE 2015 2014 £'000 £'000 Addenbrookes Hospital - 129 Cardiff University 208 1,928 Derriford Combined Laboratories - 219 Hammersmith Hospital - 45 Imperial College 1,714 1,142 Institute of Cancer Research 219 1,665 King’s College Hospital 365 - King’s College London 5,433 1,832 MRC Toxicology Unit 171 - Newcastle University 687 - Nottingham University Hospital NHS Trust - 60 Oxford University Hospitals NHS Trust 119 - Queen Mary University London 2,588 - Queen’s University Belfast - 154 Southampton General Hospital 2,294 - St James’s University Hospital - 2 The Babraham Institute 291 120 The University of Manchester - 33 University College Hospital London 1,005 - University College London 712 1,751 University of Birmingham 8,828 3,770 University of Bristol - 235 University of Cambridge 1,090 1,239 University of Edinburgh - 488 University of Glasgow 1,896 1,169 University Hospital Southampton NHS Foundation Trust 297 - University of Leeds 249 717 University of Leicester 142 - University of Liverpool - 43 University of Manchester - 443 University of Newcastle - 2,050 Bloodwise trading as Leukaemia & Lymphoma Research Company limited by guarantee 738089 Registered charity 216032 (England & Wales) SC037529 (Scotland)
Bloodwise 63 Notes to the Accounts for the year ended 31 March 2015 Notes to the accounts for the year ended 31 March 2015 (continued) 12 GRANTS APPROVED IN THE YEAR, SHOWN BY INSTITUTION – GROUP AND BLOODWISE (continued) 2015 2014 £ ‘000 £’000 University of Nottingham - 46 University of Oxford 977 3,364 University of Southampton 918 388 University of Sussex 222 - Wellcome Trust Sanger Institute 104 - 30,529 23,032 Supplements to existing grants 1,558 192 Leukaemia & Lymphoma Society US 106 Wellcome Trust – Open Access 104 Grants approved by the Board of Trustees during the year (note 11) 32,297 23,224 Bloodwise trading as Leukaemia & Lymphoma Research Company limited by guarantee 738089 Registered charity 216032 (England & Wales) SC037529 (Scotland)
Page 1 and 2:
Leukaemia & Lymphoma Research 1 Not
Page 3 and 4:
Bloodwise 3 Report of the Trustees
Page 5 and 6:
Bloodwise 5 Report of the Trustees
Page 7 and 8:
Bloodwise 7 STRATEGIC REPORT STRATE
Page 9 and 10:
Bloodwise 9 STRATEGIC REPORT GOAL 1
Page 11 and 12: Bloodwise 11 STRATEGIC REPORT HIDIN
Page 13 and 14: Bloodwise 13 STRATEGIC REPORT FUELL
Page 15 and 16: Bloodwise 15 STRATEGIC REPORT Cradd
Page 17 and 18: Bloodwise 17 STRATEGIC REPORT RESEA
Page 19 and 20: Bloodwise 19 STRATEGIC REPORT 2. PR
Page 21 and 22: Bloodwise 21 STRATEGIC REPORT A VOI
Page 23 and 24: Bloodwise 23 STRATEGIC REPORT and n
Page 25 and 26: Bloodwise 25 STRATEGIC REPORT GOAL
Page 27 and 28: Bloodwise 27 STRATEGIC REPORT GOAL
Page 29 and 30: Bloodwise 29 STRATEGIC REPORT OUR S
Page 31 and 32: Bloodwise 31 STRATEGIC REPORT THE Y
Page 33 and 34: Bloodwise 33 STRATEGIC REPORT REGIO
Page 39 and 40: Bloodwise 39 STRATEGIC REPORT INVES
Page 41 and 42: Bloodwise 41 STRATEGIC REPORT In Fe
Page 43 and 44: Bloodwise 43 HOW WE HOW WORK WE Our
Page 45 and 46: Bloodwise 45 HOW WE WORK OUR APPLIC
Page 47 and 48: Bloodwise 47 STATEMENT OF TRUSTEE R
Page 49 and 50: Bloodwise 49 INDEPENDENT AUDITOR’
Page 51 and 52: Bloodwise 51 Group statement of fin
Page 53 and 54: Bloodwise 53 Group cash flow statem
Page 55 and 56: Bloodwise 55 Accounting policies fo
Page 57 and 58: Bloodwise 57 Notes to the Accounts
Page 61: Bloodwise 61 Notes to the Accounts
Page 67 and 68: Bloodwise 67 Report of the Trustees
show all

CANCER

You also want an ePaper? Increase the reach of your titles

Delete template?

Save as template?